Alnylam Pharmaceuticals, Inc. (LON: 0HD2)
London
· Delayed Price · Currency is GBP · Price in USD 267.77
+11.98 (4.68%)
Jan 22, 2025, 7:06 PM BST
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of 27.91 billion as of January 23, 2025. Its market cap has increased by 49.61% in one year.
Market Cap
27.91B
Enterprise Value
27.87B
Revenue
1.56B
Ranking
n/a
PE Ratio
n/a
Stock Price
267.77
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 63.23M to 27.91B, an increase of 44,049.22%. That is a compound annual growth rate of 34.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |